Singedas, Newnamae .

HRN: 22-74-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
MUPIROCIN 2%, 15G (TUBE)
07/05/2025
07/11/2025
TOPICAL
2%
OD
Post Op
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines